158 Open-Label Study of Pimavanserin Patients With Comorbid Parkinson’s Disease and Depression

CNS Spectrums - United Kingdom
doi 10.1017/s1092852920000747
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cambridge University Press (CUP)

Related search

An Open Study of Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant Depression With Parkinson’s Disease

Clinical Neurophysiology
Sensory SystemsNeurologyPhysiology
2007English

Pimavanserin in Parkinson’s Disease-Induced Psychosis: A Literature Review

Cureus
2019English

Recognizing Depression in Patients With Parkinson’s Disease: Accuracy and Specificity of Two Depression Rating Scale

Arquivos de Neuro-Psiquiatria
Biological PsychiatryNeurology
2006English

Comorbid Depression and Psychosis in Parkinson’s Disease: A Report of 62,783 Hospitalizations in the United States

Cureus
2019English

An Open-Label Trial of Riluzole in Patients With Treatment-Resistant Major Depression

American Journal of Psychiatry
PsychiatryMental Health
2004English

Prevalence of Depression in Parkinson’s Disease Patients in Ethiopia

Journal of Clinical Movement Disorders
2014English

Determinants of Depression in Patients With Comorbid Depression Following Cardiac Rehabilitation

Open Heart
Cardiovascular MedicineCardiology
2019English

Effect of Repeated Intravenous Amantadine Infusions in Patients With Parkinson's Disease: An Open‐Label Pilot Study

Clinical and Translational Science
GeneticsMolecular BiologyPharmacologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2019English

Anxiety and Depression in Parkinson’s Disease

Behavioural Neurology
MedicineNeurologyPhysiological PsychologyNeuropsychology
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy